Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22